HIMS
HIMS's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.
HIMS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 50x | 81x | 39% lower-39% |
| PE percentile | 21 | 50 | 58% lower-58% |
| EPS | -$0.63 | -$0.12 | $0.50 lower-$0.50 |
| FCF | $89.9M | $42.3M | 112% higher+112% |
| Loading historical comparisons… | |||
HIMS’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Turning positive |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
HIMS’s outlook is generally improving, supported by an expected return to profitability.
HIMS PE Valuation
This table applies HIMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
HIMS Earnings Per Share
This chart tracks HIMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
HIMS Quarterly Revenue
This chart tracks HIMS's quarterly revenue over time and shows how sales are changing from year to year.
HIMS Free Cash Flow
This chart tracks HIMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
HIMS Total Shares
This chart tracks changes in HIMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
HIMS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
HIMS PE vs Healthcare Sector
This chart compares HIMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
HIMS Weekly Price
This chart uses HIMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
HIMS Weekly Moving Averages
This chart compares HIMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
HIMS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
VEEV
VEEV's valuation appears fair, fundamentals are above averages and forward estimates point to improving growth and profitability.
VEEV vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 43x | 72x | 40% lower-40% |
| PE percentile | 11 | 50 | 79% lower-79% |
| EPS | $6.08 | $3.52 | 73% higher+73% |
| FCF | $1.6B | $944.8M | 74% higher+74% |
| Loading historical comparisons… | |||
VEEV’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
VEEV Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Broad |
| Estimate dispersion | Tight |
VEEV’s outlook is generally improving, with growth expectations supporting the valuation case.
VEEV PE Valuation
This table applies VEEV's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
VEEV Earnings Per Share
This chart tracks VEEV's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
VEEV Quarterly Revenue
This chart tracks VEEV's quarterly revenue over time and shows how sales are changing from year to year.
VEEV Free Cash Flow
This chart tracks VEEV's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
VEEV Total Shares
This chart tracks changes in VEEV's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
VEEV Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
VEEV PE vs Healthcare Sector
This chart compares VEEV's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
VEEV Weekly Price
This chart uses VEEV's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
VEEV Weekly Moving Averages
This chart compares VEEV's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
VEEV Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.